Cargando…
How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?
BACKGROUND: One of the questions in the design of cancer clinical trials with combination of two drugs is in which order to administer the drugs. This is an important question, especially in the case where one agent may interfere with the effectiveness of the other agent. RESULTS: In the present pap...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427900/ https://www.ncbi.nlm.nih.gov/pubmed/30894166 http://dx.doi.org/10.1186/s12918-019-0706-y |